Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Malignant neoplasm progression
ADR ID BADD_A05037
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
16.16.01.005      Malignant neoplasm progression
Description Not Available
MedDRA Code 10051398
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Malignant neoplasm aggravated | Neoplasm malignant aggravated | Malignant neoplasm progression | Progression of pre-existing cancer
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02365Vismodegib--
BADD_D02369Voriconazole--
BADD_D02373Warfarin--
BADD_D02392Zoledronic acid0.140345%
BADD_D02405Lutetium lu 177 dotatate-
BADD_D02406Radium ra 223 dichloride--
BADD_D02412Octreotide0.035285%
BADD_D02433Salbutamol--
BADD_D02438Enoxaparin--
BADD_D02443Tiotropium--
BADD_D02453Midostaurin0.000208%
BADD_D02454Panobinostat0.001390%
BADD_D02459Dalteparin0.003314%
BADD_D02470Nintedanib--
BADD_D02472Sonidegib0.000208%
BADD_D02481Naldemedine0.002546%
BADD_D02482Acalabrutinib0.000903%
BADD_D02483Ribociclib0.002919%
BADD_D02486Niraparib0.000556%
BADD_D02495Duvelisib0.000556%
BADD_D02498Abemaciclib0.001876%
BADD_D02500Alpelisib0.000556%
BADD_D02503Telotristat ethyl-
BADD_D02509Brigatinib0.000556%
BADD_D02510Rucaparib0.030788%
BADD_D02524Ivosidenib0.000139%
The 5th Page    First    Pre   5    Total 5 Pages